PROCEPT BioRobotics (Nasdaq: PRCT) today announced two milestones in its WATER IV prostate cancer clinical program: ...
Procept BioRobotics (Nasdaq:PRCT) announced that it received FDA investigational device exemption (IDE) for a second ...
Updateddata across two dose levels of 200 mW/cm and 400 mW/cmin LA-PDAC trialshow71% (5/7) patients resected following VTP with a consistent and well-tolerated safety profile- ...
Roswell Park urology experts shared studies at AUA 2026 on bladder and prostate cancer risk, pelvic floor neural mapping and ...
Oncology experts from all over the world will discuss the latest developments in care. The American Society of Clinical ...
Pelvic floor physical therapists share the best exercises to strengthen your pelvic floor. Here's how to do them.
AstraZeneca’s IMFINZI ® (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) induction and maintenance therapy has been approved in the US for the treatment of adult patients with BCG-naïve ...
On April 21, 2026, Biocon announced that Health Canada granted a Notice of Compliance (NOC) for BOSAYA TM (denosumab) and VEVZUO TM (denosumab), biosimilars of Amgen’s Prolia® (denosumab) and Xgeva® ...
Among men with high-risk localized prostate cancer, those receiving neoadjuvant apalutamide combination therapy had improved potency recovery by 12 months and reduced rates of positive margins ...
I’m 70 years old, and my whole family is prone to edema, varicose veins and deep vein thrombosis due to venous insufficiency.
Researchers found that women who had undergone colorectal adenoma resection still showed gut microbiome and fecal metabolome ...
I read about a new treatment for Alzheimer’s disease called NeuralCIM from Cuba. Do you think this is real? — J.B.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results